BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 37467278)

  • 1. Antivenom preclinical efficacy testing against Asian snakes and their availability in Asia: A systematic review.
    Soopairin S; Patikorn C; Taychakhoonavudh S
    PLoS One; 2023; 18(7):e0288723. PubMed ID: 37467278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical antivenom-efficacy testing reveals potentially disturbing deficiencies of snakebite treatment capability in East Africa.
    Harrison RA; Oluoch GO; Ainsworth S; Alsolaiss J; Bolton F; Arias AS; Gutiérrez JM; Rowley P; Kalya S; Ozwara H; Casewell NR
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0005969. PubMed ID: 29045429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ending the drought: new strategies for improving the flow of affordable, effective antivenoms in Asia and Africa.
    Williams DJ; Gutiérrez JM; Calvete JJ; Wüster W; Ratanabanangkoon K; Paiva O; Brown NI; Casewell NR; Harrison RA; Rowley PD; O'Shea M; Jensen SD; Winkel KD; Warrell DA
    J Proteomics; 2011 Aug; 74(9):1735-67. PubMed ID: 21640209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antivenom for European Vipera species envenoming.
    Lamb T; de Haro L; Lonati D; Brvar M; Eddleston M
    Clin Toxicol (Phila); 2017 Jul; 55(6):557-568. PubMed ID: 28349771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antivenom for snakebite envenoming in Sri Lanka: the need for geographically specific antivenom and improved efficacy.
    Keyler DE; Gawarammana I; Gutiérrez JM; Sellahewa KH; McWhorter K; Malleappah R
    Toxicon; 2013 Jul; 69():90-7. PubMed ID: 23454626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An analysis of preclinical efficacy testing of antivenoms for sub-Saharan Africa: Inadequate independent scrutiny and poor-quality reporting are barriers to improving snakebite treatment and management.
    Ainsworth S; Menzies SK; Casewell NR; Harrison RA
    PLoS Negl Trop Dis; 2020 Aug; 14(8):e0008579. PubMed ID: 32817682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential economic and clinical implications of improving access to snake antivenom in five ASEAN countries: A cost-effectiveness analysis.
    Patikorn C; Ismail AK; Zainal Abidin SA; Othman I; Chaiyakunapruk N; Taychakhoonavudh S
    PLoS Negl Trop Dis; 2022 Nov; 16(11):e0010915. PubMed ID: 36383562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review and meta-analysis on the efficacy of Indian polyvalent antivenom against the Indian snakes of clinical significance.
    Gopal G; Selvaraj H; Venkataramanan SK; Venkataraman S; Saravanan K; Bibina C; Ambi SV
    Arch Toxicol; 2024 Feb; 98(2):375-393. PubMed ID: 38153416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omics meets biology: application to the design and preclinical assessment of antivenoms.
    Calvete JJ; Sanz L; Pla D; Lomonte B; Gutiérrez JM
    Toxins (Basel); 2014 Dec; 6(12):3388-405. PubMed ID: 25517863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological profile of antivenoms: preclinical analysis of the efficacy of a polyspecific antivenom through antivenomics and neutralization assays.
    Gutiérrez JM; Lomonte B; Sanz L; Calvete JJ; Pla D
    J Proteomics; 2014 Jun; 105():340-50. PubMed ID: 24583507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Harnessing the Cross-Neutralisation Potential of Existing Antivenoms for Mitigating the Outcomes of Snakebite in Sub-Saharan Africa.
    Khochare S; Jaglan A; Rashmi U; Dam P; Sunagar K
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phylovenomics of Daboia russelii across the Indian subcontinent. Bioactivities and comparative in vivo neutralization and in vitro third-generation antivenomics of antivenoms against venoms from India, Bangladesh and Sri Lanka.
    Pla D; Sanz L; Quesada-Bernat S; Villalta M; Baal J; Chowdhury MAW; León G; Gutiérrez JM; Kuch U; Calvete JJ
    J Proteomics; 2019 Sep; 207():103443. PubMed ID: 31325606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vulnerability to snakebite envenoming: a global mapping of hotspots.
    Longbottom J; Shearer FM; Devine M; Alcoba G; Chappuis F; Weiss DJ; Ray SE; Ray N; Warrell DA; Ruiz de Castañeda R; Williams DJ; Hay SI; Pigott DM
    Lancet; 2018 Aug; 392(10148):673-684. PubMed ID: 30017551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a new polyspecific antivenom for snakebite envenoming in Sri Lanka: Analysis of its preclinical efficacy as compared to a currently available antivenom.
    Villalta M; Sánchez A; Herrera M; Vargas M; Segura Á; Cerdas M; Estrada R; Gawarammana I; Keyler DE; McWhorter K; Malleappah R; Alape-Girón A; León G; Gutiérrez JM
    Toxicon; 2016 Nov; 122():152-159. PubMed ID: 27720977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antivenom therapy of carpet viper (Echis ocellatus) envenoming: effectiveness and strategies for delivery in West Africa.
    Habib AG; Warrell DA
    Toxicon; 2013 Jul; 69():82-9. PubMed ID: 23339853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Situation of snakebite, antivenom market and access to antivenoms in ASEAN countries.
    Patikorn C; Ismail AK; Abidin SAZ; Blanco FB; Blessmann J; Choumlivong K; Comandante JD; Doan UV; Mohamed Ismail Z; Khine YY; Maharani T; Nwe MT; Qamruddin RM; Safferi RS; Santamaria E; Tiglao PJG; Trakulsrichai S; Vasaruchapong T; Chaiyakunapruk N; Taychakhoonavudh S; Othman I
    BMJ Glob Health; 2022 Mar; 7(3):. PubMed ID: 35296460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond the 'big four': Venom profiling of the medically important yet neglected Indian snakes reveals disturbing antivenom deficiencies.
    Senji Laxme RR; Khochare S; de Souza HF; Ahuja B; Suranse V; Martin G; Whitaker R; Sunagar K
    PLoS Negl Trop Dis; 2019 Dec; 13(12):e0007899. PubMed ID: 31805055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the efficacy of Taiwanese freeze-dried neurotoxic antivenom against Naja kaouthia, Naja siamensis and Ophiophagus hannah through proteomics and animal model approaches.
    Liu CC; You CH; Wang PJ; Yu JS; Huang GJ; Liu CH; Hsieh WC; Lin CC
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006138. PubMed ID: 29244815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antivenomics and in vivo preclinical efficacy of six Latin American antivenoms towards south-western Colombian Bothrops asper lineage venoms.
    Mora-Obando D; Pla D; Lomonte B; Guerrero-Vargas JA; Ayerbe S; Calvete JJ
    PLoS Negl Trop Dis; 2021 Feb; 15(2):e0009073. PubMed ID: 33524033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Snake venomics and antivenomics: Proteomic tools in the design and control of antivenoms for the treatment of snakebite envenoming.
    Gutiérrez JM; Lomonte B; León G; Alape-Girón A; Flores-Díaz M; Sanz L; Angulo Y; Calvete JJ
    J Proteomics; 2009 Mar; 72(2):165-82. PubMed ID: 19344652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.